Congenital heart defects (CHDs) are the most common birth defects, affecting approximately 1 in every 100 babies born worldwide. These structural abnormalities of the heart can range from mild to severe, impacting heart function and circulation.
CHDs develop during fetal development when the heart does not form properly. While the exact causes are often unknown, factors such as genetics, maternal health, exposure to certain medications or toxins during pregnancy, and environmental factors may contribute to their development.
The symptoms and severity of CHDs vary depending on the type and complexity of the defect. Some babies may exhibit symptoms shortly after birth, such as rapid breathing, poor feeding, or bluish skin color (cyanosis), while others may remain asymptomatic until later in life.
Early diagnosis and intervention are critical for managing CHDs and improving outcomes. Treatment options may include medications, minimally invasive procedures, or surgery to repair the defect and improve heart function.
Supportive care and ongoing monitoring are essential for children and adults living with CHDs. Access to specialized cardiac care, rehabilitation services, and psychosocial support can help individuals and families navigate the challenges associated with CHDs and optimize quality of life.
By raising awareness, advocating for access to care, and supporting research efforts, we can improve outcomes and enhance the lives of individuals affected by congenital heart defects. Together, let’s strive for a future where every child born with a CHD can thrive and reach their full potential.
